{"id":970693,"date":"2026-06-04T09:29:01","date_gmt":"2026-06-04T13:29:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/"},"modified":"2026-06-04T09:29:01","modified_gmt":"2026-06-04T13:29:01","slug":"autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/","title":{"rendered":"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &#8220;What This Means&#8221; Segment Featuring City of Hope Chief of Medicine"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <i>Dr. Toufic Kachaamy Discusses Visceral Cancer Pain Treatment Differentiation, Pancreatic Cancer Feasibility Data, and Peripheral Nervous System Platform Potential\u00a0<\/i>\n      <\/p>\n<p align=\"center\">\n        <i>Access the segment <\/i><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CPPZU5VnSQA8w3-nzqQfqMDhS_3FeR_fPpusINa6qZEETHzcC7HikSjnOlxlKC5cwsjuzU20CIsfsL5_ShM-1xmVs49caYJfnvTlPFoum14=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <i>here<\/i><br \/>\n        <\/a><br \/>\n        \n      <\/p>\n<p align=\"justify\">\n        <b>THE WOODLANDS, TX, June  04, 2026  (GLOBE NEWSWIRE) &#8212; <\/b><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nKeOFWJVjIVDmqNCEvwKYqTw7gkLycd39mPnqy-5-3d0xqulNAfonnIcFAqAtHvR5uXLC164_oO-SkHPGPCpYJlx7QDcq9txcTQXZml4_kQ-b27_xeolRx7UmVnaGOGtkhVAQPOMEPlmpUrC59bLkftmR2WERQOjH9hwW2E2iZCDrGndbebvOBzpSGPXDZZ5yu9VMOeqxulk2Qtzs5CQQBtKsChJnTQm4zv-2oEfO9_qBsterPAQ1m2Fhz-Ld2XMzmvtJ5sni0PSdO9-_a7iMw==\" rel=\"nofollow\" target=\"_blank\">Autonomix Medical, Inc.<\/a>\u202f(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d),\u00a0a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that it recently participated in a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=biTAc5aTVAmb7o2NStci8km7aM-xE_vE4soz5q5-CdLQwAwTA31qN3q-IQeqg7-kbOJSZXt9ZSJiRAVqfknr593szEbPiEH5G-FcrmhfxfTigKhPiFAX4EGAoN6q0wD4haUtT0gfkYw5-dijs3LzhA==\" rel=\"nofollow\" target=\"_blank\">Virtual Investor \u201cWhat This Means\u201d<\/a> segment.<\/p>\n<p align=\"justify\">For the segment, Key Opinion Leader and Chief of Medicine at City of Hope in Phoenix, Dr. Toufic Kachaamy, discussed the clinical significance of data presented by Autonomix Medical at the Society of Surgical Oncology Annual Meeting (SSO), highlighting the importance of the work being selected for a podium presentation and its relevance to the surgical oncology community. The segment explored the potential clinical impact of the Company\u2019s approach to managing visceral cancer pain, how it differs from existing treatment techniques, and why those differences may matter in practice. Dr. Kachaamy also addressed the broader applicability of the findings beyond pancreatic cancer and discussed how the results support the ongoing clinical development and feasibility of the technology platform.<\/p>\n<p align=\"justify\">The \u201cWhat This Means\u201d segment can be accessed <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CPPZU5VnSQA8w3-nzqQfqMgQGdhfRb_BxaDz2A8FIXpzYO42kTcw1ZSvBzppRKOfQm4I-iIbRoxOQd3M9bgxCy1i8mJWAH2N2vnooT8X_ck=\" rel=\"nofollow\" target=\"_blank\">here<\/a>.<\/p>\n<p align=\"justify\">\n        <b>About Autonomix Medical, Inc.\u00a0<\/b>\n      <\/p>\n<p align=\"justify\">Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company\u2019s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever,\u00a0transvascular\u00a0diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.\u00a0<\/p>\n<p align=\"justify\">We are initially developing this technology for the treatment of pain, with\u00a0initial\u00a0trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology\u00a0constitutes\u00a0a platform to address dozens of potential indications, including cardiology,\u00a0hypertension\u00a0and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.\u00a0<br \/>\u00a0<br \/>For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V_2FknyBsAVKeZsWmsAT6BK064gjRauzh_btGLFB_XX8RWmPZ7UtwBeNUs6TLRA_zgFwJNCYUknDJR74q7Ewdg==\" rel=\"nofollow\" target=\"_blank\">autonomix.com<\/a>\u00a0and connect with the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Bz5WOHi1CvIIXv3d2-1MbB06ak_4Ed-jR1b-JAC7MDUdn3Klpbl5jIZmI7wuCaTNBuzh5Y95RKoWJGxvqh4X1A==\" rel=\"nofollow\" target=\"_blank\">X<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X_yWK8RSpNwitoXPYPwb_E7X460l-d3O2cWvK3dUcBjrP2tZ39p-_8vPHrmoAH31meugrmFBRWEXCWvx9R3gl2P_iYMnDLkKuCRNSi_NZvgKFe59pyP2OroN_YIs17Xk\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a><u>,\u00a0<\/u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jxQUmsvd5zsEddjx3z6KhY6x3nUUCYq8mbTUVJG45XvGm2KbR9zVAjYAftvgRJLOHK8C20C90-acyo2YS2f9xlrgme7hju33y5wmfV8Q1HM=\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n_scNTpknqdGUGWMJoDBdol865QNgcyOZPRMT5wL_Yr9FXGSuZpqR7X8p-490E8syMFyCTVL7Hle5vaqwToA_oOYUxZKA9TosNQkq_n1GZdQftUNKPmAcJpeghmt0wR7\" rel=\"nofollow\" target=\"_blank\">Facebook<\/a>. <br \/><b>\u00a0<\/b><br \/><b>Forward Looking Statements\u00a0<\/b><\/p>\n<p align=\"justify\">Some of the statements in this release are \u201cforward-looking statements,\u201d which involve risks and uncertainties. Such forward-looking statements can be identified\u00a0by the use of\u00a0words such as \u201cshould,\u201d \u201cmight,\u201d \u201cmay,\u201d \u201cintends,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201cprojects,\u201d \u201cforecasts,\u201d \u201cexpects,\u201d \u201cplans,\u201d and \u201cproposes.\u201d\u00a0Forward-looking statements in this press release and in the video include, but are not limited to, expectations\u00a0regarding\u00a0the potential effectiveness and clinical benefits of\u00a0Autonomix&#8217;s\u00a0nerve-targeted treatments for pancreatic cancer pain and other conditions, the capabilities of the Company&#8217;s platform technology, and the potential applicability of the technology across multiple indications.\u00a0<br \/>\u00a0<br \/>Although Autonomix believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are\u00a0a number of\u00a0risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading \u201cRisk Factors\u201d and elsewhere in the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (SEC) on May 27, 2026, and from time to time, our other filings with the SEC. Forward-looking statements speak only as of the date of\u00a0this press release\u00a0and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law.\u00a0<\/p>\n<p align=\"justify\">\n        <b>Investor and Media Contact\u00a0<\/b><br \/>\n        <br \/>JTC Team, LLC\u00a0<br \/>Jenene Thomas <br \/>908.824.0775 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V_2FknyBsAVKeZsWmsAT6JlY4nTFGlKJUlNURIfn9ixODc_pVA1PPF1F-bq8F1YrfE19WNm0i6bVbc0KS45fsVi3Yp9DVgcZhgLITOhkl60=\" rel=\"nofollow\" target=\"_blank\">autonomix@jtcir.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDIzMDhiN2YtMGFkZC00NWZiLWE2NmYtZjE4ZGQ0YzVkYzg0LTUwMDExOTk5Mi0yMDI2LTA2LTA0LWVu\/tiny\/Autonomix-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Toufic Kachaamy Discusses Visceral Cancer Pain Treatment Differentiation, Pancreatic Cancer Feasibility Data, and Peripheral Nervous System Platform Potential\u00a0 Access the segment here THE WOODLANDS, TX, June 04, 2026 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc.\u202f(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d),\u00a0a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that it recently participated in a Virtual Investor \u201cWhat This Means\u201d segment. For the segment, Key Opinion Leader and Chief of Medicine at City of Hope in Phoenix, Dr. Toufic Kachaamy, discussed the clinical significance of data presented by Autonomix Medical at the Society of Surgical Oncology Annual Meeting (SSO), highlighting the importance of the work being selected for a podium presentation and its relevance to the surgical oncology &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &#8220;What This Means&#8221; Segment Featuring City of Hope Chief of Medicine&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-970693","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &quot;What This Means&quot; Segment Featuring City of Hope Chief of Medicine - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &quot;What This Means&quot; Segment Featuring City of Hope Chief of Medicine - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dr. Toufic Kachaamy Discusses Visceral Cancer Pain Treatment Differentiation, Pancreatic Cancer Feasibility Data, and Peripheral Nervous System Platform Potential\u00a0 Access the segment here THE WOODLANDS, TX, June 04, 2026 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc.\u202f(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d),\u00a0a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that it recently participated in a Virtual Investor \u201cWhat This Means\u201d segment. For the segment, Key Opinion Leader and Chief of Medicine at City of Hope in Phoenix, Dr. Toufic Kachaamy, discussed the clinical significance of data presented by Autonomix Medical at the Society of Surgical Oncology Annual Meeting (SSO), highlighting the importance of the work being selected for a podium presentation and its relevance to the surgical oncology &hellip; Continue reading &quot;Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &#8220;What This Means&#8221; Segment Featuring City of Hope Chief of Medicine&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-04T13:29:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &#8220;What This Means&#8221; Segment Featuring City of Hope Chief of Medicine\",\"datePublished\":\"2026-06-04T13:29:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/\"},\"wordCount\":618,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/\",\"name\":\"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor \\\"What This Means\\\" Segment Featuring City of Hope Chief of Medicine - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==\",\"datePublished\":\"2026-06-04T13:29:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &#8220;What This Means&#8221; Segment Featuring City of Hope Chief of Medicine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor \"What This Means\" Segment Featuring City of Hope Chief of Medicine - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/","og_locale":"en_US","og_type":"article","og_title":"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor \"What This Means\" Segment Featuring City of Hope Chief of Medicine - Market Newsdesk","og_description":"Dr. Toufic Kachaamy Discusses Visceral Cancer Pain Treatment Differentiation, Pancreatic Cancer Feasibility Data, and Peripheral Nervous System Platform Potential\u00a0 Access the segment here THE WOODLANDS, TX, June 04, 2026 (GLOBE NEWSWIRE) &#8212; Autonomix Medical, Inc.\u202f(NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d),\u00a0a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that it recently participated in a Virtual Investor \u201cWhat This Means\u201d segment. For the segment, Key Opinion Leader and Chief of Medicine at City of Hope in Phoenix, Dr. Toufic Kachaamy, discussed the clinical significance of data presented by Autonomix Medical at the Society of Surgical Oncology Annual Meeting (SSO), highlighting the importance of the work being selected for a podium presentation and its relevance to the surgical oncology &hellip; Continue reading \"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &#8220;What This Means&#8221; Segment Featuring City of Hope Chief of Medicine\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-04T13:29:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &#8220;What This Means&#8221; Segment Featuring City of Hope Chief of Medicine","datePublished":"2026-06-04T13:29:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/"},"wordCount":618,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/","name":"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor \"What This Means\" Segment Featuring City of Hope Chief of Medicine - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==","datePublished":"2026-06-04T13:29:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTczMTY0OSM3NjM2MTA5IzUwMDExOTk5Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-highlights-clinical-data-presented-at-society-of-surgical-oncology-annual-meeting-in-virtual-investor-what-this-means-segment-featuring-city-of-hope-chief-of-medicine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor &#8220;What This Means&#8221; Segment Featuring City of Hope Chief of Medicine"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/970693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=970693"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/970693\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=970693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=970693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=970693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}